{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:51:52Z","timestamp":1740135112406,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["0073947"],"award-info":[{"award-number":["0073947"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Life-long immunosuppressive treatment after liver transplantation (LT) prevents graft rejection but predisposes the LT recipient to infections. Herpesvirus infections are associated with morbidity and mortality among LT recipients. Among those, especially cytomegalovirus (CMV) and varicella-zoster virus (VZV) pose challenges after LT. The aim of this study is to provide an in-depth characterization of the cellular immune response against CMV and VZV infections in LT recipients and identify potential risk factors for infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Herpesvirus Infections in Solid Organ Transplant Recipients \u2013 Liver Transplant Study (HISTORY) consists of an epidemiological and immunological substudy. <jats:italic>The epidemiological substudy<\/jats:italic> is a retrospective observational cohort study that includes all patients who underwent LT in Denmark between 2010 and 2023 (<jats:italic>N\u2009\u2248<\/jats:italic>\u2009500). Using data from nationwide hospital records and national health registries, the incidence of and clinical risk factors for CMV and VZV infections will be determined. <jats:italic>The immunological substudy<\/jats:italic> is an explorative prospective observational cohort study including patients enlisted for LT in Denmark during a 1.5-year period (<jats:italic>N<\/jats:italic>\u2009&gt;\u200980). Participants will be followed with scheduled blood samples until 12 months after LT. CMV- and VZV-derived peptides will be predicted for their likelihood to be presented in participants based on their HLA type. Peptide-MHC complexes (pMHC) will be produced to isolate CMV- and VZV-specific T cells from peripheral blood mononuclear cells before and after CMV and VZV infection. Their frequency, T cell receptor sequences, and phenotypic characteristics will be examined, and in a subset of participants, CMV- and VZV-specific T cells will be expanded ex vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study will provide novel insight into T cell immunity required for viral control of CMV and VZV and has the potential to develop a prediction model to identify LT recipients at high risk for infection based on a combination of clinical and immunological data. Furthermore, this study has the potential to provide proof-of-concept for adoptive T cell therapy against CMV and VZV. Combined, this study has the potential to reduce the burden and consequence of CMV and VZV infections and improve health and survival in LT recipients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov (NCT05532540), registered 8 September 2022.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08153-8","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T14:02:53Z","timestamp":1680789773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Herpesvirus immunology in solid organ transplant recipients \u2013 liver transplant study (HISTORY): a retrospective and prospective observational cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Moises Alberto","family":"Suarez-Zdunek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil Kumar","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Ross","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian Rask","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemette","family":"Hald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Georg","family":"Hillings\u00f8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sine Reker","family":"Hadrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne Dam","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"key":"8153_CR1","unstructured":"Scandiatransplant. Annual report 2020 Scandiatransplant office. 2020. http:\/\/www.scandiatransplant.org\/resources\/AnnualScandiatransplantdatareport_2020.pdf. Accessed 2 Mar 2021."},{"key":"8153_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5500\/wjt.v10.i7.183","volume":"10","author":"BC Lizaola-Mayo","year":"2020","unstructured":"Lizaola-Mayo BC, Rodriguez EA. Cytomegalovirus infection after liver transplantation. World J Transplant. 2020;10:183\u201390.","journal-title":"World J Transplant"},{"key":"8153_CR3","doi-asserted-by":"crossref","unstructured":"Razonable RR, Humar A. Cytomegalovirus in solid organ transplantation. Am J Transplant. 2013;13 SUPPL.4:93\u2013106.","DOI":"10.1111\/ajt.12103"},{"key":"8153_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3109\/00365548.2010.549836","volume":"43","author":"C da Cunha-Bang","year":"2011","unstructured":"da Cunha-Bang C, S\u00f8rensen SS, Iversen M, Sengel\u00f8v H, Hilings\u00f8 JG, Rasmussen A, et al. Factors associated with the development of cytomegalovirus infection following solid organ transplantation. Scand J Infect Dis. 2011;43:360\u20135.","journal-title":"Scand J Infect Dis"},{"key":"8153_CR5","doi-asserted-by":"publisher","first-page":"e13674","DOI":"10.1111\/tid.13674","volume":"23","author":"DE Kwon","year":"2021","unstructured":"Kwon DE, Lee HS, Lee KH, La Y, Han SH, Song YG. Incidence of herpes zoster in adult solid organ transplant recipients: a meta-analysis and comprehensive review. Transpl Infect Dis. 2021;23:e13674.","journal-title":"Transpl Infect Dis"},{"key":"8153_CR6","doi-asserted-by":"publisher","first-page":"645718","DOI":"10.3389\/fimmu.2021.645718","volume":"12","author":"MML Kho","year":"2021","unstructured":"Kho MML, Roest S, Bov\u00e9e DM, Metselaar HJ, Hoek RAS, van der Eijk AA, et al. Herpes zoster in solid organ transplantation: incidence and risk factors. Front Immunol. 2021;12:645718.","journal-title":"Front Immunol"},{"key":"8153_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1186\/s12879-020-05648-6","volume":"20","author":"C Mu\u00f1oz-Quiles","year":"2020","unstructured":"Mu\u00f1oz-Quiles C, L\u00f3pez-Lacort M, D\u00edez-Domingo J, Orrico-S\u00e1nchez A. Herpes zoster risk and burden of disease in immunocompromised populations: a population-based study using health system integrated databases, 2009\u20132014. BMC Infect Dis. 2020;20:905.","journal-title":"BMC Infect Dis"},{"key":"8153_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT. The danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390.","journal-title":"Clin Epidemiol"},{"issue":"Suppl 7","key":"8153_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1403494811399958","volume":"39","author":"K Helweg-Larsen","year":"2011","unstructured":"Helweg-Larsen K. The danish Register of Causes of Death. Scand J Public Health. 2011;39(Suppl 7):26\u20139.","journal-title":"Scand J Public Health"},{"key":"8153_CR10","first-page":"798","volume":"46","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Schmidt SAJ, Wallach-Kildemoes H, S\u00f8rensen HT, Hallas J, Schmidt M. Data Resource Profile: the danish national prescription Registry. Int J Epidemiol. 2017;46:798\u2013798\u00a0f.","journal-title":"Int J Epidemiol"},{"key":"8153_CR11","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","volume":"199","author":"V Jurtz","year":"2017","unstructured":"Jurtz V, Paul S, Andreatta M, Marcatili P, Peters B, Nielsen M. NetMHCpan-4.0: improved Peptide-MHC class I Interaction predictions integrating eluted ligand and peptide binding Affinity Data. J Immunol. 2017;199:3360\u20138.","journal-title":"J Immunol"},{"key":"8153_CR12","doi-asserted-by":"publisher","first-page":"eabf7550","DOI":"10.1126\/sciimmunol.abf7550","volume":"6","author":"SK Saini","year":"2021","unstructured":"Saini SK, Hersby DS, Tamhane T, Povlsen HR, Amaya Hernandez SP, Nielsen M, et al. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 + T cell activation in COVID-19 patients. Sci Immunol. 2021;6:eabf7550.","journal-title":"Sci Immunol"},{"key":"8153_CR13","unstructured":"Cohen J, Straus S, Arvin A. Varicella-zoster virus. In: Knipe D, Howley P, editors. Fields virology. 5th edition. Philadephia, PA: Lippincott Williams & Wilkins; 2007. p.\u00a02773\u2013819."},{"key":"8153_CR14","doi-asserted-by":"publisher","unstructured":"Povlsen HR, Bentzen AK, Kadivar M, Jessen LE, Hadrup SR, Nielsen M, ATRAP - Accurate T. cell Receptor Antigen Pairing through data-driven filtering of sequencing information from single-cells. Preprint. bioRxiv. 2022. https:\/\/doi.org\/10.1101\/2022.08.31.506001. Accessed 2 Feb 2023.","DOI":"10.1101\/2022.08.31.506001"},{"key":"8153_CR15","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/cid\/ciy696","volume":"68","author":"RF Chemaly","year":"2019","unstructured":"Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, et al. Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials. Clin Infect Dis. 2019;68:1420\u20136.","journal-title":"Clin Infect Dis"},{"key":"8153_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1600-6143.2009.02872.x","volume":"10","author":"GR Hill","year":"2010","unstructured":"Hill GR, Tey SK, Beagley L, Crough T, Morton JA, Clouston AD, et al. Successful immunotherapy of HCMV disease using virus-specific T cells expanded from an allogeneic stem cell transplant recipient. Am J Transplant. 2010;10:173\u20139.","journal-title":"Am J Transplant"},{"key":"8153_CR17","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","volume":"35","author":"I Tzannou","year":"2017","unstructured":"Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, et al. Off-the-Shelf Virus-Specific T cells to treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections after allogeneic hematopoietic stem-cell transplantation. J Clin Oncol. 2017;35:3547\u201357.","journal-title":"J Clin Oncol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08153-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08153-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08153-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T14:03:23Z","timestamp":1680789803000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08153-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8153"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08153-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2023,4,6]]},"assertion":[{"value":"7 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The immunological substudy has been approved by the Ethics Committee of the Capital Region of Denmark (H-22039226) and the Knowledge Centre for Data Reviews of the Capital Region of Denmark (P-2022-952), and participants provide oral and written consent. As data for the epidemiological substudy are collected from hospital records, the substudy is exempt from provision of informed consent in accordance with Danish law and has been approved by the Centre for Regional Development of the Capital Region of Denmark (R-20051155) and the Knowledge Centre for Data Reviews of the Capital Region of Denmark (P-2020-839).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S.R. Hadrup is the inventor of the antigen scaffold technology, E Patent Appl No. 16205918.2 and 18178769.8, license to PokeACell (S.R. Hadrup as co-founder). S.D.N. has received unrestricted research grants from Novo Nordisk Foundation, Lundbeck Foundation, Augustinus Foundation, and Rigshospitalet Research Council, and reports advisory board activity for Gilead Sciences and GlaxoSmithKline\/ViiV Healthcare, all unrelated to this manuscript. The other authors report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}